SillaJen CEO arrested on insider trading charges
The Seoul Southern District Court issued the warrant earlier in the day, following requests from prosecutors last week that included other SillaJen executives suspected of illegally dumping shares.
The company's stock price plummeted in August on the news that Pexa-Vec, SillaJen's anticancer drug candidate, had failed its Phase 3 clinical trial.
Before the announcement, Moon had sold 2.92 million shares of SillaJen and made around 250 billion won ($204 million). Moon is also suspected of illegally increasing his control of SillaJen through a shell company in March 2014.
The local court previously issued arrest warrants for two former SillaJen executives in relation to the case.
SillaJen debuted on the secondary Kosdaq in December 2016. The Korea Exchange is expected to announce May 29 whether the company should remain on the Kosdaq after indefinitely suspending trading of SillaJen shares on May 4 in response to the allegations of criminal conduct within the company.
BY KO JUN-TAE [firstname.lastname@example.org]